<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ETH-Z-UNICEF-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Emergency Funding to support procurement of essential commodities and services in conflict affected regions of Northern Ethiopia. - Ethiopia (01-Oct-2024-30-Sep-2025)</narrative>
    </title>
    <description type="1">
      <narrative>Ethiopia, Multicomponent, United Nations Children's Fund</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To support critical emergency fund response in the conflict affected areas in Tigray, Amhara, Afar and Oromia, between October 2024 and September 2025. Objectives: To contribute to restoring TB, HIV and Malaria response in conflict affected areas in Northern Ethiopia; To complement the efforts of Federal Ministry of Health.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Children's Fund</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Children's Fund</narrative>
    </participating-org>
    <other-identifier ref="ETH-Z-UNICEFP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2024-10-01" />
    <activity-date type="2" iso-date="2024-10-01" />
    <activity-date type="3" iso-date="2025-09-30" />
    <activity-date type="4" iso-date="2025-09-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ET" percentage="100">
      <narrative>Ethiopia</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12262" percentage="85.61">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="11.79">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="2.6">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="be1b5900-2300-4fc2-b142-10ef3d0c2a60" percentage="1.18">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Epidemic preparedness</narrative>
        </description>
      </budget-item>
      <budget-item code="738953d0-45d2-486f-957e-e3fee8de75cd" percentage="11.75">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="c0797acd-77a1-43ee-9c39-6bf17fd6f4ed" percentage="24.29">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Integrated community case management (iCCM)</narrative>
        </description>
      </budget-item>
      <budget-item code="1c40e6d5-39ce-4815-b8c6-a88d14097c71" percentage="3.14">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Social and behavior change (SBC) (Case management)</narrative>
        </description>
      </budget-item>
      <budget-item code="0904e74b-3fd7-4544-bb4e-8343228bdbe5" percentage="45.25">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Mass campaign: universal</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="10.54">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="1.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="2.59">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">2543781.07</value>
    </budget>
    <capital-spend percentage="2.24" />
    <transaction ref="bf70e71f-cb59-4cff-9934-2c22f360e3a3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-05" />
      <value currency="USD" value-date="2024-12-05">2543781.00</value>
      <description>
        <narrative>Global Fund commitment to ETH-Z-UNICEFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Children's Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1558401b-e263-4b69-9142-ae93b77427b7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-12" />
      <value currency="USD" value-date="2024-12-12">2543781.00</value>
      <description>
        <narrative>Global Fund disbursement to ETH-Z-UNICEFP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Children's Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ETH-Z-UNICEFP01-EXP-20250331">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-03-31" />
      <value currency="USD" value-date="2025-03-31">1981863.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Children's Fund for ETH-Z-UNICEFP01, Oct 2024 to Mar 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Children's Fund</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ETH-Z-UNICEF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ETH/2023/TB_HIV/en/ETH-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - TB/HIV - Ethiopia - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1619-ETH-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ETH/2023/Malaria/en/ETH-M_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - Malaria - Ethiopia - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1620-ETH-M.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="100">
          <comment>
            <narrative>Numerator: 53520; Denominator: 53520.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31" value="100">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 44956; Denominator: 44956.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31" value="100">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 8563; Denominator: 8563.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="29.91">
            <comment>
              <narrative>Numerator: 8005; Denominator: 26760.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="29.91">
            <comment>
              <narrative>Numerator: 8005; Denominator: 26760.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 66117; Denominator: 66117.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 73946; Denominator: 73946.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 10360; Denominator: 10360.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="63">
          <comment>
            <narrative>Numerator: 218969; Denominator: 347570.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31" value="63">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 183934; Denominator: 291959.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="38.25">
            <comment>
              <narrative>Numerator: 93061; Denominator: 243299.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="76.5">
            <comment>
              <narrative>Numerator: 186123; Denominator: 243299.</narrative>
            </comment>
          </target>
          <actual value="97.71">
            <comment>
              <narrative>Numerator: 189343; Denominator: 193780.</narrative>
            </comment>
          </actual>
          <actual value="98.2">
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 205927; Denominator: 209712.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 6.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1; Denominator: 6; Percentage: 16.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1; Denominator: 6; Percentage: 16.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 5; Denominator: 6; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 5; Denominator: 6; Percentage: 83.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 1; Denominator: 6; Percentage: 16.67%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 7.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 360.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 315; Denominator: 360; Percentage: 87.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2025" iso-date="2025-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 216; Denominator: 360; Percentage: 60%.</narrative>
          </comment>
        </baseline>
        <baseline year="2026" iso-date="2026-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 328; Denominator: 360; Percentage: 91.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2027" iso-date="2027-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 92; Denominator: 360; Percentage: 25.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2028" iso-date="2028-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 144; Denominator: 360; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <baseline year="2029" iso-date="2029-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 32; Denominator: 360; Percentage: 8.89%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 189.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 315.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 347.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 218.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 222.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 97.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 144.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 227.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 103; Denominator: 360; Percentage: 28.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 103; Denominator: 360; Percentage: 28.61%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 57; Denominator: 189; Percentage: 30.16%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 189; Denominator: 315; Percentage: 60%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 162; Denominator: 289; Percentage: 56.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 222.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>